GLP-1 |
ΔAmax31, pg/mL |
−19 (−28 to −11) |
−3.0 (−6.4, 0.2) |
Acid instability (LE3, LE4) |
|
ΔAmax41, pg/mL |
−17 (−26 to −10) |
−2.6 (−5.4, 0.5) |
→ lower GLP-1 peak in rats and in humans |
|
ΔAOB41, pg/mL·h |
−39 (−59 to −13) |
−3 (−57, 75) |
Acid instability and redispersibility (LE4) |
|
|
|
|
→ less GLP-1 release only in rats |
PYY |
ΔAmax31, pg/mL |
−240 (−332 to −166) |
−47 (−79, −19) |
Acid instability (LE3, LE4) |
|
ΔAmax41, pg/mL |
−166 (−266 to −108) |
−44 (−79, −15) |
→ lower PYY peak in rats and humans |
|
Δtmax41, min |
−26 (−47 to −4) |
−178 (−369, −39) |
Acid instability and redispersibility (LE4) |
|
Δtmax43, min |
−94 (−142 to −50) |
−336 (−802, −31) |
→ earlier PYY peak in rats and humans |
|
ΔAOB31, pg/mL·h |
−354 (−579 to −104) |
−343 (−912, 522) |
Acid instability and no redispersibility (LE3) |
|
|
|
|
→ less PYY release only in rats |
|
Δtmax31, min |
65 (35 to 123) |
151 (−132, 599) |
Acid instability and no redispersibility (LE3) |
|
|
|
|
→ delayed PYY peak only in rats |
TAG |
Δtmax31, min |
53 (12 to 99) |
−146 (−352, 11) |
Acid instability and no redispersibility (LE3) |
|
|
|
|
→ earlier TAG peak only in rats |
|
dAmax31 |
−0.1 (−0.2, 0.1) |
−0.4 (−0.6, −0.2) |
Acid instability and no redispersibility (LE3) |
|
dAOB31 |
4 (−35, 47) |
−236 (−439, −105) |
→ lower TAG peak and release only in humans |
BHB |
Δtmax31, min |
35 (0.5 to 76) |
42 (−169, 216) |
Acid instability and no redispersibility (LE3) |
|
|
|
|
→ delayed BHB peak only in rats |
FFA |
|
|
|
No emulsion effect neither in rats nor in humans |